These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12010415)

  • 21. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease and haemophilia: prospect at the new millennium.
    Liras A
    Haemophilia; 2000 Nov; 6(6):716-8. PubMed ID: 11122406
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.
    Sabin CA; Pasi KJ; Phillips AN; Lilley P; Bofill M; Lee CA
    BMJ; 1996 Jan; 312(7025):207-10. PubMed ID: 8563582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of central venous catheters (portacaths) in children with haemophilia.
    Bollard CM; Teague LR; Berry EW; Ockelford PA
    Haemophilia; 2000 Mar; 6(2):66-70. PubMed ID: 10781190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee of the UKHCDO. United Kingdom Haemophilia Centre Directors' Organisation.
    Ludlam CA
    Lancet; 1997 Dec; 350(9092):1704. PubMed ID: 9400534
    [No Abstract]   [Full Text] [Related]  

  • 27. The risk associated with indwelling catheters in children with haemophilia.
    Ljung R
    Br J Haematol; 2007 Sep; 138(5):580-6. PubMed ID: 17686052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective neuropathological review of prion disease in UK haemophilic patients.
    Lee CA; Ironside JW; Bell JE; Giangrande P; Ludlam C; Esiri MM; McLaughlin JE
    Thromb Haemost; 1998 Dec; 80(6):909-11. PubMed ID: 9869159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging clinical concerns in the ageing haemophilia patient.
    Konkle BA; Kessler C; Aledort L; Andersen J; Fogarty P; Kouides P; Quon D; Ragni M; Zakarija A; Ewenstein B
    Haemophilia; 2009 Nov; 15(6):1197-209. PubMed ID: 19686466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging needs of persons living with haemophilia and HIV/AIDS in British Columbia.
    Taylor G
    Haemophilia; 1999 Jan; 5(1):1-8. PubMed ID: 10215941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemophilia patient had variant CJD agent in spleen.
    Eaton L
    BMJ; 2009 Feb; 338():b705. PubMed ID: 19224963
    [No Abstract]   [Full Text] [Related]  

  • 32. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal aspects of haemophilia.
    Economou M; Banov L; Ljung R
    Eur J Haematol Suppl; 2014 Aug; 76():21-5. PubMed ID: 24957104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
    Batlle J; Villar A; Liras A; Alonso C; Altisent C; Brito D; Moreno M; Lucía F; Sedano C; Prieto M; Calvente N; Aznar JA; Jiménez V; Soriano V; Martorell JR; Iruín G; Bergua JM; Aguilar C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):333-40. PubMed ID: 18600079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of central venous access devices in paediatric haemophilia patients.
    Domm JA; Hudson MG; Janco RL
    Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancement in the treatment of haemophilia.
    Bhardwaj R; Rath G; Goyal AK
    Int J Biol Macromol; 2018 Oct; 118(Pt A):289-295. PubMed ID: 29928908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forum on: the role of recombinant factor VIII in children with severe haemophilia A.
    Franchini M; Coppola A; Molinari AC; Santoro C; Schinco P; Speciale V; Tagliaferri A
    Haemophilia; 2009 Mar; 15(2):578-86. PubMed ID: 19187188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety surveillance in haemophilia and allied disorders.
    Lassila R; Makris M
    J Intern Med; 2016 Jun; 279(6):515-23. PubMed ID: 27001233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and supply of haemophilia products: worldwide perspectives.
    Farrugia A
    Haemophilia; 2004 Jul; 10(4):327-33. PubMed ID: 15230945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality management and quality assurance in haemophilia care: a model at the Bonn haemophilia centre.
    Brackmann HH; Effenberger W; Schwaab R; Hess L; Hanfland P; Oldenburg J
    Haemophilia; 2002 May; 8(3):211-6. PubMed ID: 12010413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.